A client who has just experienced a pulmonary embolism is administered alteplase (Activase). Which of the following side effects associated with this medication would the nurse assess for?
Hypokalemia
Internal bleeding
pancytopenia
Hypertension
The Correct Answer is B
A. Hypokalemia is not a common side effect of alteplase; instead, it may result from other factors.
B. Internal bleeding is a significant risk associated with thrombolytics like alteplase, as they promote the breakdown of clots but can also affect hemostasis.
C. Pancytopenia is not directly associated with alteplase use; it may occur with other medications or conditions.
D. Hypertension is not a common side effect of alteplase; instead, blood pressure may fluctuate but is not typically increased as a direct result of the medication.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is {"A":{"answers":"C"},"B":{"answers":"A"},"C":{"answers":"B"},"D":{"answers":"D"}}
Explanation
Warfarin: Vitamin K is the primary reversal agent for anticoagulation with warfarin. It helps restore normal clotting factor production in the liver.
Heparin: Protamine sulfate is the specific reversal agent for heparin, neutralizing its anticoagulant effects.
Rivaroxaban: Andexanet alfa is a specific reversal agent for rivaroxaban and other Factor Xa inhibitors, reversing their anticoagulant effects.
Beta Blockers: While there is no specific reversal agent, glucagon can help increase heart rate and myocardial contractility in cases of beta-blocker overdose.
Correct Answer is A
Explanation
A. Argatroban is specifically indicated for patients with heparin-induced thrombocytopenia (HIT), as it is a direct thrombin inhibitor that does not cause further platelet depletion.
B. Myocardial infarction is treated with different classes of anticoagulants or antiplatelet medications, not specifically argatroban.
C. Gastrointestinal bleeding would generally be a contraindication to anticoagulation therapy rather than an indication for argatroban use.
D. Hepatotoxicity could be a concern when using argatroban, especially as it is metabolized in the liver, but it does not indicate a need for this medication.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.